Phibro Animal Health Corporation (PAHC) support and resistance · P/E 13, rev $1.52B
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Phibro Animal Health Corporation (PAHC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
PAHC currently screens at market cap $1.25B and trailing P/E 13.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PAHC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PAHC quote page for the session range and the stock page for the full model.
Not investment advice.